Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +335.41%
#4 aPriori aPriori +160.22%
#5 Bedrock Bedrock +74.34%
#6 Cysic Cysic +50.91%
#7 Prom Prom +46.77%
#8 Playnance Playnance +34.90%
#9 Bitway Bitway +28.95%
#10 COTI COTI +25.85%
Coin of the day
Wrapped One Wrapped One
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
EFFECTOR Therapeutics, Inc. EFFECTOR Therapeutics, Inc.

EFFECTOR Therapeutics, Inc.

EFTRW
Classificação em ações #42260
eFFECTOR Therapeutics, Inc. is a biopharmaceutical firm currently in the... eFFECTOR Therapeutics, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective translation regulator inhibitors aimed at combating cancer. Their primary investigational drug, Tomivosertib, is an orally administered small-molecule MNK inhibitor currently undergoing Phase 2b clinical trials. This candidate is being evaluated for its efficacy in patients suffering from metastatic non-small cell lung cancer. Additionally, the company is advancing zotatifin, another small molecule engineered to block eukaryotic initiation factor 4A (eIF4E). Zotatifin is presently in Phase 1/2 clinical studies for individuals with various solid tumors. Furthermore, it's being tested in a Phase 2a open-label expansion cohort, in conjunction with fulvestrant and abemaciclib, for patients afflicted with ER-positive breast cancer. eFFECTOR Therapeutics, Inc. also holds a research collaboration and licensing pact with Pfizer Inc., focused on co-developing eIF4E inhibitors. Established in 2012, the company maintains its corporate headquarters in Solana Beach, California.
Preço da ação
$0.0006
Última sincronização: 2025-11-25
Valor de mercado
$2.82K
Variação (1 dia)
59,900.00%
Variação (1 ano)
59,900.00%
País
US
Negociar EFFECTOR Therapeutics, Inc. (EFTRW)

Categoria

Healthcare
Histórico de preços das ações de EFFECTOR Therapeutics, Inc. (EFTRW)
Preço de fecho mais alto: $0.00 em 2025-11-01

Preço de fecho mais baixo: $0.98 em 2021-03-01
Histórico de preços das ações da EFFECTOR Therapeutics, Inc. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 0.00%
2025 59,900.00%
2024 -100.00%
2023 12.00%
2022 -85.79%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR